Showing results (931-940 of 945) with videos related to
Sort By:
Pageof 95
The Journal of Pharmacology and Experimental Therapeutics|June 18, 2022
Tralesinidase Alfa Enzyme Replacement Therapy Prevents Disease Manifestations in a Canine Model of Mucopolysaccharidosis Type IIIBN Matthew Ellinwood, Bethann N Valentine, Andrew S Hess, et al.Cureus|July 30, 2021
A Retrospective Observational Study: Is Absolute Lymphocyte Count a Prognostic Marker in COVID-19?Mansoor Zafar, Muhammad Shahbaz, Mangala Karkhanis, et al.Nature|March 29, 2018
Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1Evanna L Mills, Dylan G Ryan, Hiran A Prag, et al.Molecular Psychiatry|March 10, 2004
Multicenter linkage study of schizophrenia loci on chromosome 22qB J Mowry, P A Holmans, A E Pulver, et al.Circulation|May 1, 2023
Orally Bioavailable Macrocyclic Peptide That Inhibits Binding of PCSK9 to the Low Density Lipoprotein ReceptorDouglas G Johns, Louis-Charles Campeau, Puja Banka, et al.Nature Communications|May 15, 2024
Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathwaysNaziia Kurmasheva, Aida Said, Boaz Wong, et al.Human Molecular Genetics|January 30, 2014
An inherited duplication at the gene p21 Protein-Activated Kinase 7 (PAK7) is a risk factor for psychosisDerek W Morris, Richard D Pearson, Paul Cormican, et al.Molecular Psychiatry|September 15, 2010
GWA study data mining and independent replication identify cardiomyopathy-associated 5 (CMYA5) as a risk gene for schizophreniaX Chen, G Lee, B S Maher, et al.Physical Review Letters|March 21, 2008
First observation of the Greisen-Zatsepin-Kuzmin suppressionR U Abbasi, T Abu-Zayyad, M Allen, et al.Physical Review Letters|May 21, 2010
Indications of proton-dominated cosmic-ray composition above 1.6 EeVR U Abbasi, T Abu-Zayyad, M Al-Seady, et al.Pageof 95